Compounds represented by the general formula (1):
[wherein R1 is typically an aminoalkyl group; R2 is typically a hydrogen atom, a lower alkyl group, R3 or SR4 (where R4 is typically a lower alkyl group); Ar is typically a 5-membered aromatic heterocyclic group] have an NOS inhibiting activity and are useful as therapeutics of cerebrovascular diseases and other pharmaceuticals.
通式(1)所代表的化合物:
[其中 R1 通常为
氨基烷基;R2 通常为氢原子、低级烷基、R3 或 SR4(其中 R4 通常为低级烷基);Ar 通常为 5 元芳香杂环基团]具有 NOS 抑制活性,可用于治疗脑血管疾病和其他药物。